Pathogenic variants in FGFR2 are primarily associated with skeletal dysplasias characterized by craniosynostosis as a key feature, while bone fragility and osteoporosis are not commonly recognized manifestations. This evidence concerns the gene FGFR2 and craniosynostosis.